Article By:
Zacks Investment Research
Wednesday, July 20, 2022 8:47 AM EDT
Biogen Inc. came out with quarterly earnings of $5.25 per share.
In this article: BIIB
Alert: Alzheimer’s Drug Fails In Clinical Trial - Stocks Sink
What are the chances of $BIIB and $TSRO being bought out? They have long been targets, or at least rumored to be, for consolidation.